ArticleJournal of Korean medical science2026
Evaluating the Efficacy of AI-Assisted Quantitative Coronary Angiography in Reducing Procedural Time for Primary PCI in STEMI Patients: A Retrospective Analysis.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Human-AI Collaboration in Healthcare: A Scoping Review.NPJ digital medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRapid reperfusion is crucial in ST-elevation myocardial infarction (STEMI). We investigated whether AI-assisted quantitative coronary angiography (QCA) can reduce the procedure time for primary percutaneous coronary intervention (PCI) in patients with STEMI.
methodsThis single-center, retrospective study compared primary PCI assisted by MPXA, an AI-based QCA software, with angiography-guided PCI in 1,041 patients with STEMI. To minimize potential bias, a 1:3 propensity score matching was performed between the treatment and control groups. The primary endpoint was the time from coronary angiography to PCI completion. The secondary endpoints included total contrast media volume during the procedure, in-hospital mortality, and in-hospital cardiac death.
resultsAfter propensity score matching, 164 and 492 patients in the AI-QCA-assisted and angiography-guided groups, respectively, were analyzed. The AI-QCA-assisted PCI group showed significant reduction in procedure time than the angiography-guided PCI group (34.9 ± 13.9 vs. 39.5 ± 17.1 minutes,
conclusionAI-assisted QCA significantly reduced the overall procedure time of primary PCI for STEMI, primarily by streamlining stent sizing and optimization processes without decreasing contrast use. Given that STEMI procedures typically begin with small-diameter balloon inflation to maintain blood flow and minimize complications, the time saved by optimal stent deployment could be clinically beneficial by allowing faster complete reperfusion. Larger studies are needed to confirm the potential clinical benefit of reducing the procedure time using AI-QCA in STEMI treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.